Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
Liesbeth Renemana,b,
Charles B. L. M. Majoieb,
Herman Flickb and
Gerard J. den Heetenb
a Graduate School of Neurosciences, Department of Nuclear Medicine, Academic Medical Center, Amsterdam, the Netherlands
b Graduate School of Neurosciences, Department of Radiology, Academic Medical Center, Amsterdam, the Netherlands

View larger version (64K):
[in a new window]
|
FIG 1. Proton density-weighted MR image (4000/22) shows the three voxel locations for the localized 1H MRS studies: midfrontal gray matter (left), mid-occipital gray matter (middle), and right parietal white matter (right).
| |

View larger version (16K):
[in a new window]
|
FIG 2. Proton MRS spectra from the midfrontal gray matter region in a control subject (age, 23 years) and an MDMA user (cumulative lifetime exposure, 200 tablets; age, 26 years). The spectrum in the MDMA user is representative for the whole group and shows a reduction in NAA levels, with Cr levels similar to those in the control subject. Note that MI levels are elevated in this specific MDMA user, although for the group as a whole, mean MI measures in MDMA users did not statistically differ from those of control subjects.
| |

View larger version (11K):
[in a new window]
|
FIG 3. Plot shows the correlation between the NAA/Cr ratio in the frontal cortex and the extent of previous MDMA use.
| |